Literature DB >> 19811462

PD-1 but not CTLA-4 blockage abrogates the protective effect of regulatory T cells in a pregnancy murine model.

Paul Ojiambo Wafula1, Ana Teles, Anne Schumacher, Kerstin Pohl, Hideo Yagita, Hans-Dieter Volk, Ana Claudia Zenclussen.   

Abstract

PROBLEM: Regulatory T cells (Treg) play an important role in fetal protection. They expand during normal pregnancy and protect paternal/fetal antigens from rejection by maternal effector cells. Accordingly, the transfer of Treg obtained from BALB/c-mated CBA/J females prevents abortion in DBA/2J-mated animals. The actual mechanism through which Treg mediate their protective effect is still inconclusive. Cytotoxic T lymphocyte antigen-4 (CTLA-4) and Programmed cell death 1 (PD-1) are some of known Treg-associated molecules; however, their role in Treg-mediated fetal protection in murine model has not been investigated. METHOD OF STUDY: Treg obtained from normal pregnant animals (NP; CBA/J x BALB/c) on day 14 were adoptively transferred into abortion-prone mice (AP; CBA/J x DBA/2J) intravenously on day 2 of pregnancy. An amount of 250 microg of either anti-PD-1 or anti-CTLA-4 mAb were injected intraperitoneally on days 0, 3, 6 and 9 of pregnancy. Controls received Treg + IgG or Treg + PBS. NP or AP treated with PBS served as additional controls.
RESULTS: Blocking PD-1 abrogated the protective effect of Treg, resulting in a higher median abortion rate in comparison with the Treg/isotype-treated control while CTLA-4 blockage did not interfere with the protective effect of Treg. This was associated with a diminished number of vascular endothelial growth factor-A(+) cells, previously reported as stimulators of lymphocyte extravasation in preterm labor.
CONCLUSION: Our data suggest PD-1 as an important mediator in Treg-induced fetal protection in the CBA/J x DBA/2J murine model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19811462     DOI: 10.1111/j.1600-0897.2009.00737.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  21 in total

Review 1.  Immunity, thyroid function and pregnancy: molecular mechanisms.

Authors:  Anthony P Weetman
Journal:  Nat Rev Endocrinol       Date:  2010-04-27       Impact factor: 43.330

2.  Maternal CD4⁺ and CD8⁺ T cell tolerance towards a fetal minor histocompatibility antigen in T cell receptor transgenic mice.

Authors:  Antoine L Perchellet; Susmita Jasti; Margaret G Petroff
Journal:  Biol Reprod       Date:  2013-10-31       Impact factor: 4.285

3.  Co-inhibitory molecules: Controlling the effectors or controlling the controllers?

Authors:  Govindarajan Thangavelu; Christa Smolarchuk; Colin C Anderson
Journal:  Self Nonself       Date:  2010-02-16

Review 4.  Innate immunity, decidual cells, and preeclampsia.

Authors:  Chang-Ching Yeh; Kuan-Chong Chao; S Joseph Huang
Journal:  Reprod Sci       Date:  2012-07-18       Impact factor: 3.060

5.  The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance.

Authors:  Francesca D'Addio; Leonardo V Riella; Bechara G Mfarrej; Lola Chabtini; La Tonya Adams; Melissa Yeung; Hideo Yagita; Miyuki Azuma; Mohamed H Sayegh; Indira Guleria
Journal:  J Immunol       Date:  2011-09-26       Impact factor: 5.422

Review 6.  Immunology of hepatic diseases during pregnancy.

Authors:  Lars Bremer; Christoph Schramm; Gisa Tiegs
Journal:  Semin Immunopathol       Date:  2016-06-20       Impact factor: 9.623

Review 7.  The T helper type 17/regulatory T cell paradigm in pregnancy.

Authors:  Ana Sofia Figueiredo; Anne Schumacher
Journal:  Immunology       Date:  2016-05       Impact factor: 7.397

8.  Demystifying animal models of adverse pregnancy outcomes: touching bench and bedside.

Authors:  Elizabeth A Bonney
Journal:  Am J Reprod Immunol       Date:  2013-02-28       Impact factor: 3.886

Review 9.  To drive or be driven: the path of a mouse model of recurrent pregnancy loss.

Authors:  Elizabeth A Bonney; Stephen A Brown
Journal:  Reproduction       Date:  2014-04-08       Impact factor: 3.906

Review 10.  Cancer Immunotherapy: Factors Important for the Evaluation of Safety in Nonclinical Studies.

Authors:  Danuta J Herzyk; Helen G Haggerty
Journal:  AAPS J       Date:  2018-02-07       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.